Fionda, Cinzia <br/><br/>
Heat shock protein-90 inhibitors increase MHC class I-related chain A and B ligand expression on multiple myeloma cells and their ability to trigger NK cell degranulation.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  Oct 2009 
 - 4385-94 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1550-6606 
<br/><br/><label>Standard No.: </label>10.4049/jimmunol.0901797  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Benzoquinones--pharmacology<br/>Boronic Acids--pharmacology<br/>Bortezomib<br/>Cell Degranulation--drug effects<br/>Cell Line, Tumor<br/>GPI-Linked Proteins<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>HSP90 Heat-Shock Proteins--antagonists & inhibitors<br/>Histocompatibility Antigens Class I--biosynthesis<br/>Humans<br/>Intercellular Signaling Peptides and Proteins--biosynthesis<br/>Killer Cells, Natural--immunology<br/>Lactams, Macrocyclic--pharmacology<br/>Ligands<br/>Multiple Myeloma--immunology<br/>Protein Folding--drug effects<br/>Pyrazines--pharmacology<br/>Up-Regulation--drug effects